- Cart - 0 item(s)
- $0.00
Your shopping cart is empty!
- Chemistry
- Bioactive Molecules
- Anti-infection
- Apoptosis
- Autophagy
- Cell Cycle/DNA Damage
- Cytoskeleton
- Epigenetics
- GPCR/G Protein
- Immunology/Inflammation
- JAK/STAT Signaling
- MAPK/ERK Pathway
- Membrane Transporter/Ion Channel
- Metabolic Enzyme/Protease
- Neuronal Signaling
- NF-κB
- PI3K/Akt/mTOR
- PROTAC
- Protein Tyrosine Kinase/RTK
- Stem Cell/Wnt
- TGF-beta/Smad
- Vitamin D Related/Nuclear Receptor
- Others
- Methylation
- Cytoskeletal Signaling
- Natural Products
- Alkaloids
- Amino acid
- Anthraquinones
- Cerebrosides
- Chalcones
- Coumarins
- Diterpenoids
- Flavonoids
- Iridoids
- Lignans
- Lipids
- Miscellaneous
- Monoterpenoids
- Other terpenes
- Phenols
- Phenylpropanoids
- Quinones
- Saccharides
- Sesquiterpenoids
- Steroids
- Tetraterpenoids
- Thiophenes
- Triterpenoids
- Xanthones
- Polyphenols
- Stibene glucosides
- Oligose
- Anthocyanins
- Miscellaneous
- Chromones
- Terpenoids
- Indoles
- Procyanidins
- Aliphatics
- Botanical Cyclopeptides
- ADCs
- Antibodies
- Multiplex IHC
- Material Science
- Others
[CAS NO. 23599-69-1] Norisoboldine
| Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
| Catalog: | HY-N0586 |
| Brand: | MCE |
| CAS: | 23599-69-1 |
Overview
| MDL | - |
|---|---|
| Molecular Weight | 313.35 |
| Molecular Formula | C18H19NO4 |
| SMILES | OC1=C(OC)C=C2CCN[C@@]3([H])CC4=CC(O)=C(OC)C=C4C1=C23 |
Summary
Norisoboldine is an orally active natural aryl hydrocarbon receptor ( AhR ) agonist. Norisoboldine, as a major isoquinoline alkaloid present in Radix Linderae, can be used for the research of Rheumatoid arthritis and Ulcerative colitis [1] [2] .
IC50 & Target
AhR [2]
In Vitro
Norisoboldine (1~30 μM; 0~24 hours; CD4+T cells) activates AhR under hypoxic microenvironment and significantly downregulates mRNA expression of miR-31
[2]
.
Norisoboldine (30 μM; 0~24 hours; CD4+T cells) inhibits glycolysis in hypoxia
[2]
.
Norisoboldine (1~30 μM; 0~72 hours; Treg cells) promotes Treg differentiation in hypoxia
[2]
.
Norisoboldine (10, 30 μM) facilitates the disassociation of HSP90/AhR complexes, the nuclear translocation of AhR, and the formation of AhR/ARNT complexes. Norisoboldine induces generation of Treg cells in hypoxia is independent of miR-31
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Western Blot Analysis [2]
| Cell Line: | CD4+T cells |
| Concentration: | 1~30 μM |
| Incubation Time: | 24 hours |
| Result: | Activated AhR in cells under hypoxic microenvironment. |
RT-PCR [2]
| Cell Line: | CD4+T cells |
| Concentration: | 1~30 μM |
| Incubation Time: | 24 hours |
| Result: | Significantly downregulated mRNA expression of miR-31. |
Immunofluorescence [2]
| Cell Line: | CD4+T cells |
| Concentration: | 30 μM |
| Incubation Time: | 24 hours |
| Result: | Inhibited glycolysis in hypoxia. |
Cell Differentiation Assay [2]
| Cell Line: | Treg cells |
| Concentration: | 1~30 μM |
| Incubation Time: | 72 hours |
| Result: | Promoted Treg differentiation in hypoxia. |
In Vivo
Norisoboldine (10~40 mg/kg; p.o.; 20 days) significantly reduces the severity of joint swelling and erythema during the course of the experiment
[1]
.
Norisoboldine (40 mg/kg; i.g.; 10 days) induces enhancement of CYP1A1 expression and suppresses expressions of Glut1 and HK2 in colons
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| Animal Model: | Male ICR mice (18–22 g) |
| Dosage: | 10~40 mg/kg |
| Administration: | P.o. |
| Result: | Significantly reduced the severity of joint swelling and erythema during the course of the experiment. |
| Animal Model: | Female C57BL/6 mice (18–22 g) |
| Dosage: | 40 mg/kg |
| Administration: | I.g. |
| Result: | Induced enhancement of CYP1A1 expression and suppressed expressions of Glut1 and HK2 in colons. |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Solvent & Solubility
DMSO : ≥ 62.5 mg/mL ( 199.46 mM )
* "≥" means soluble, but saturation unknown.
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 3.1913 mL | 15.9566 mL | 31.9132 mL |
| 5 mM | 0.6383 mL | 3.1913 mL | 6.3826 mL |
| 10 mM | 0.3191 mL | 1.5957 mL | 3.1913 mL |
-
1.
-
2.
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.08 mg/mL (6.64 mM); Clear solution
References
- [1] Luo Y, et al. Therapeutic effect of norisoboldine, an alkaloid isolated from Radix Linderae, on collagen-induced arthritis in mice. Phytomedicine. 2010;17(10):726-731.
- [2] Lv Q, et al. Norisoboldine, a natural AhR agonist, promotes Treg differentiation and attenuates colitis via targeting glycolysis and subsequent NAD+/SIRT1/SUV39H1/H3K9me3 signaling pathway. Cell Death Dis. 2018;9(3):258. Published 2018 Feb 15.
Synonyms
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.